NRSNW
NeuroSense Therapeutics Ltd. Warrant
stockNASDAQWarrant
At CloseOct 15, 2026
0.0105USD+1.952%(+0.0002)10,030
Loading…
Loading…
140,542
Healthcare
Biotechnology
HQ
Herzliya, Israel
Previous Close
$0.01
Beta
6.70
52-Week High
$0.54 2025-11-07
52-Week Low
$0.00 2026-10-13
SMA 50
$0.08
SMA 200
$0.32
Avg. Vol 10D
7,970
Avg. Vol 30D
4,079
Avg. Vol 90D
2,733
Relative Vol
0.00
23.23M
16.11M
69.34%
0.01%
1.00
84%/16%
43.81%
10.67%
82
NRSNW Profile
advancing research, development and therapy for als. neurosense therapeutics is a biotech company focusing on the development of mirnas as a novel treatment for als. currently preparing for a first clinical study in patients in usa
NRSNW Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 0.01 | 2026-10-12 | -40.10% | 2.894 |
| 1M | 0.05 | 2026-09-17 | -87.65% | 9.479 |
| 3M | 0.10 | 2026-07-16 | -93.95% | 5.695 |
| 6M | 0.16 | 2026-04-16 | -96.22% | 13.887 |
| 1Y | 0.37 | 2025-10-17 | -98.36% | 6.699 |
| 2Y | 0.13 | 2024-10-21 | -95.49% | — |
| 5Y | 1.01 | 2021-12-09 | -99.40% | -0.130 |
NRSNW Stock Summary
NeuroSense Therapeutics Ltd. Warrant (NASDAQ:NRSNW) stock price today is $0.01, and today's volume is 6. NRSNW is down 42.381% today. The 30 day average volume is 4,079. NRSNW market cap is $140,542 with 23.23M shares outstanding.